Published in J Immunol on May 15, 1998
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med (2004) 3.34
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J (1998) 3.06
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med (2000) 2.16
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A (1998) 1.81
Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis (2002) 1.46
Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol (2013) 1.18
Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol (2012) 1.16
CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J Virol (1999) 1.14
A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A (2011) 1.14
Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity. Glycoconj J (2004) 1.10
Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS One (2009) 1.05
Trafficking of endosomal Toll-like receptors. Trends Cell Biol (2014) 1.03
Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect Immun (2001) 1.01
Activation of the immune system by bacterial CpG-DNA. Immunology (2002) 0.99
CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). Clin Exp Immunol (2002) 0.97
The effects of DNA containing CpG motif on dendritic cells. Immunology (2000) 0.96
Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol Immunol (2008) 0.94
Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding. Int Immunol (2011) 0.94
Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun (2001) 0.93
Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog (2010) 0.92
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens. Immunology (2001) 0.91
Influenza-induced production of interferon-alpha is defective in geriatric individuals. J Clin Immunol (2010) 0.91
Effect of cytofectins on the immune response of murine macrophages to mammalian DNA. Immunology (2003) 0.90
Protein kinase D1: a new component in TLR9 signaling. J Immunol (2008) 0.89
The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol (2007) 0.88
CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. J Biol Chem (2008) 0.88
Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing. Arthritis Res Ther (2008) 0.88
Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol Sin (2015) 0.88
Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling. J Biol Chem (2011) 0.87
Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA. Immunology (2004) 0.86
Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells. Immunology (2000) 0.85
The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release. Antimicrob Agents Chemother (2006) 0.84
Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes. Infect Immun (2003) 0.83
Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells. Infect Immun (2006) 0.82
Proteases: essential actors in processing antigens and intracellular toll-like receptors. Front Immunol (2013) 0.81
Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling. J Biol Chem (2014) 0.80
Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats. Am J Hypertens (2016) 0.80
DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells. Immunology (2006) 0.80
CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells. Ann Rheum Dis (2001) 0.79
PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activation. Int Immunol (2009) 0.79
In vitro biocompatibility and oxidative stress profiles of different hydraulic calcium silicate cements. J Endod (2013) 0.79
Mycoplasma hyorhinis-Contaminated Cell Lines Activate Primary Innate Immune Cells via a Protease-Sensitive Factor. PLoS One (2015) 0.75
Traditional biochemical assays for studying toll-like receptor 9. J Immunoassay Immunochem (2013) 0.75
A possible cause of joint destruction in septic arthritis. Arthritis Res (1999) 0.75
Toll-like receptor 9 signaling delays neutrophil apoptosis by increasing transcription of Mcl-1. PLoS One (2014) 0.75
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A (1996) 5.26
Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med (1997) 4.06
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol (2001) 3.64
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol (2001) 3.34
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol (1998) 2.93
Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science (1998) 2.79
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol (1996) 2.74
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol (2000) 2.73
Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol (2000) 2.59
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci U S A (1997) 2.35
Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin. Nat Neurosci (2000) 2.33
Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron (1995) 2.13
Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol (1996) 2.06
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol (2004) 1.98
CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A (1999) 1.98
Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol (1998) 1.97
Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol (1998) 1.94
Negative control region at the 5' end of murine leukemia virus long terminal repeats. Mol Cell Biol (1989) 1.88
CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest (1997) 1.71
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine (2004) 1.71
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A (1998) 1.70
Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein. Neuron (1992) 1.66
Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol (2001) 1.65
Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors. J Physiol (1995) 1.60
Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum (1999) 1.59
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci U S A (1999) 1.59
Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun (2001) 1.55
Mating type and sporulation in yeast. II. Meiosis, recombination, and radiation sensitivity in an alpha-alpha diploid with altered sporulation control. Genetics (1975) 1.54
Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol (1997) 1.46
Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol (1996) 1.46
Wildlife for sale. Biologist (London) (2000) 1.45
Detection of myocardial infarction by dual-source coronary computed tomography angiography using quantitated myocardial scintigraphy as the reference standard. Heart (2009) 1.45
Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut (2004) 1.43
The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc Natl Acad Sci U S A (1996) 1.43
Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science (1999) 1.42
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine (1998) 1.35
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood (1997) 1.34
CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation. Antisense Nucleic Acid Drug Dev (2001) 1.34
CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol (1998) 1.34
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol (1998) 1.33
Enzymes of fructose metabolism in human liver. J Clin Invest (1968) 1.30
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol (2001) 1.30
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol (2000) 1.29
CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J Immunol (2000) 1.27
Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev (1994) 1.27
The inhibitory glycine receptor: architecture, synaptic localization and molecular pathology of a postsynaptic ion-channel complex. Curr Opin Neurobiol (1995) 1.26
Phosphorothioate oligodeoxynucleotides: antisense or anti-protein? Antisense Res Dev (1995) 1.26
IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol (1996) 1.21
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine (1999) 1.20
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol (1999) 1.19
Structure and functions of inhibitory and excitatory glycine receptors. Ann N Y Acad Sci (1999) 1.19
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev (2001) 1.19
Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev (1993) 1.19
CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J Immunol (1996) 1.18
The neurotransmitter receptor-anchoring protein gephyrin reconstitutes molybdenum cofactor biosynthesis in bacteria, plants, and mammalian cells. Proc Natl Acad Sci U S A (1999) 1.16
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine (2000) 1.15
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. Curr Top Microbiol Immunol (2006) 1.11
The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: implications for the fusion of myoblasts. J Cell Sci (1999) 1.11
Colocalization of gephyrin and GABAA-receptor subunits in the rat retina. J Comp Neurol (1995) 1.09
Hydrophobic interactions mediate binding of the glycine receptor beta-subunit to gephyrin. J Neurochem (1999) 1.08
Development of adult-type inhibitory glycine receptors in the central auditory system of rats. J Comp Neurol (1997) 1.07
Now I know my CpGs. Trends Microbiol (2001) 1.06
NIH conference. Systemic lupus erythematosus. Ann Intern Med (1991) 1.06
CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J Immunol (1999) 1.05
CpG ODN enhances uptake of bacteria by mouse macrophages. Clin Exp Immunol (2003) 1.05
Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int Immunol (2001) 1.04
Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol (1999) 1.04
CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol (1999) 1.03
Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev (1990) 1.03
CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther (1999) 0.99
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol (2001) 0.98
Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses. Immunol Rev (1999) 0.98
APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells. J Immunol (2000) 0.96
Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor. Blood (1998) 0.95
CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J Immunol (1998) 0.94
CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine (2000) 0.93
NIH conference. Angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med (1988) 0.93
Localization of the clustering protein gephyrin at GABAergic synapses in the main olfactory bulb of the rat. J Comp Neurol (1998) 0.92
Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood (1996) 0.92
Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev (1998) 0.92
Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria. Infect Immun (1999) 0.91
Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res (1998) 0.91
Importance of Arg-219 for correct biogenesis of alpha 1 homooligomeric glycine receptors. FEBS Lett (1993) 0.91
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens. Immunology (2001) 0.91
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther (2001) 0.91
Nerve growth factor secretion in cultured enteric glia cells is modulated by proinflammatory cytokines. J Neuroendocrinol (2006) 0.91
Diversity and phylogeny of gephyrin: tissue-specific splice variants, gene structure, and sequence similarities to molybdenum cofactor-synthesizing and cytoskeleton-associated proteins. Proc Natl Acad Sci U S A (2000) 0.90
CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol (1999) 0.90
Expression of glycine receptor alpha subunits and gephyrin in cultured spinal neurons. Eur J Neurosci (1996) 0.90
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses. Int Arch Allergy Immunol (1999) 0.89
CpG DNA: a novel immunomodulator. Trends Microbiol (1999) 0.88
Gut inflammation modulated by the enteric nervous system and neurotrophic factors. Scand J Gastroenterol (2002) 0.88
Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol (2001) 0.88
CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int Immunol (2001) 0.87